Scholarlink

Purpose <p>Cushing’s disease (CD), caused by ACTH-secreting pituitary adenomas, results in hypercortisolism. Transsphenoidal surgery (TSS) is the first-line treatment. Early postoperative cortisol trends are frequently monitored, though standard interpretation is lacking. We sought to determine whether early postoperative cortisol trajectories are associated with biochemical remission at 1 year using unsupervised machine learning.</p> Methods <p>We retrospectively reviewed 94 adult patients with CD who underwent TSS between 2011 and 2021 at two academic centers. Serum cortisol was measured every 6&#xa0;h, and the resulting time series was clustered with the goal of predicting the primary outcome of biochemical remission at 1-year follow up.</p> Results <p>Of 94 patients, 77 (82%) achieved biochemical remission. There were no significant differences in demographic or tumor characteristics between remission and non-remission groups. The nadir cortisol value for the remission group was lower than the non-remission group (4.8 [5.5] versus 19.3 [13.7]) though this difference was also not statistically significant (<i>p</i> = 0.1022). Clustering analysis identified three optimal clusters for remission subgroup. Statistically significant differences in cortisol trends were observed from 6&#xa0;h to 30&#xa0;h (p &lt; = 0.0002). At 6&#xa0;h, average cortisol values by cluster ranged from 25.51 to 61.17 mcg/dL. Two of the three clusters demonstrated an initial decrease in cortisol values, while one cluster did not immediately decrease. No significant differences in clinical, tumor, or treatment variables were observed between clusters.</p> Conclusion <p>Postoperative cortisol trajectories show distinct early patterns but are not independently predictive of 1-year biochemical remission following TSS for CD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Unsupervised clustering analysis reveals distinct postoperative cortisol trajectories following pituitary adenoma resection in Cushing’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Rushmin Khazanchi,
  • Sachin Govind,
  • Rishi Jain,
  • Joshua Vignolles-Jeong,
  • Vikas Munjal,
  • Rahul Chaliparambil,
  • Mark Damante,
  • James P. Chandler,
  • Luma Ghalib,
  • Wenyu Huang,
  • Stephen T. Magill,
  • Daniel M. Prevedello

摘要

Purpose

Cushing’s disease (CD), caused by ACTH-secreting pituitary adenomas, results in hypercortisolism. Transsphenoidal surgery (TSS) is the first-line treatment. Early postoperative cortisol trends are frequently monitored, though standard interpretation is lacking. We sought to determine whether early postoperative cortisol trajectories are associated with biochemical remission at 1 year using unsupervised machine learning.

Methods

We retrospectively reviewed 94 adult patients with CD who underwent TSS between 2011 and 2021 at two academic centers. Serum cortisol was measured every 6 h, and the resulting time series was clustered with the goal of predicting the primary outcome of biochemical remission at 1-year follow up.

Results

Of 94 patients, 77 (82%) achieved biochemical remission. There were no significant differences in demographic or tumor characteristics between remission and non-remission groups. The nadir cortisol value for the remission group was lower than the non-remission group (4.8 [5.5] versus 19.3 [13.7]) though this difference was also not statistically significant (p = 0.1022). Clustering analysis identified three optimal clusters for remission subgroup. Statistically significant differences in cortisol trends were observed from 6 h to 30 h (p < = 0.0002). At 6 h, average cortisol values by cluster ranged from 25.51 to 61.17 mcg/dL. Two of the three clusters demonstrated an initial decrease in cortisol values, while one cluster did not immediately decrease. No significant differences in clinical, tumor, or treatment variables were observed between clusters.

Conclusion

Postoperative cortisol trajectories show distinct early patterns but are not independently predictive of 1-year biochemical remission following TSS for CD.